Cellectar Biosciences Inc...
0.25
-0.03 (-9.09%)
At close: Jan 15, 2025, 11:52 AM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04
Net Income -37.98M -28.60M -24.12M -15.09M -14.09M -13.24M -13.56M -6.18M -5.50M -8.11M -10.78M -8.80M -7.44M 2.10M -22.27M -16.45M -19.56M -8.29M -3.05M -815.28K
Depreciation & Amortization 192.38K 148.44K 149.91K 141.45K 132.80K 82.27K 1.55M 356.67K 362.50K 367.20K 424.76K 497.25K 584.84K 35.34K 32.35K 16.89K 15.37K 9.52K 3.24K 2.54K
Stock-Based Compensation 2.41M 1.45K 1.12K 467.54 866.79 721.21K 758.76K 529.16K 447.30K 850.35K 2.32M 1.50M 907.46K 337.30K 864.34K 453.33K 503.29K 588.04K n/a n/a
Other Working Capital -224.39K 60.21K -212.96K -109.36K 266.00K -310.26K -192.07K -466.70K -7.45K 78.62K 55.89K n/a -8.14K -239.65K -1.40K 361.39K 285.74K 348.19K n/a 99.45K
Other Non-Cash Items -471.95K 93.82K 77.72K 66.48K 56.56K 1.56M -22.07K 529.16K 447.30K 426.46K 2.32M 1.50M -7.44M 819.00K 12.11M 453.33K 503.29K 588.04K 833.05K 9.82K
Deferred Income Tax n/a n/a 2.94K -185.28K -43.00K n/a n/a -3.79M -3.71M -2.23M -3.94M -1.47M 7.71M -8.12M n/a -446.86K -503.29K -588.04K n/a n/a
Change in Working Capital 3.48M 1.68M 198.76K 671.24K 1.39M -569.05K 259.26K 273.81K -265.52K -149.49K 500.99K 177.55K -303.11K -2.97M -1.36M -1.36M 5.57M 1.22M -181.99K 413.75K
Operating Cash Flow -32.38M -25.22M -22.57M -13.93M -11.69M -11.44M -11.02M -8.28M -8.21M -8.84M -9.15M -6.59M -5.97M -7.80M -10.62M -17.33M -13.47M -6.47M -2.40M -389.18K
Capital Expenditures -864.04K -225.97K -141.36K -62.35K -24.54K -384.99K -346.70K -72.25K -58.47K -29.57K -147.81K -97.69K -118.41K n/a -18.00K -49.00K -24.37K -10.72K -25.85K -3
Acquisitions n/a n/a n/a n/a n/a 55.00K n/a n/a n/a n/a n/a n/a 905.65K n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a n/a 55.00K n/a n/a n/a n/a 2.00M -2.00M 500.00K n/a n/a 1.18M 466.07K -1.43M -226.32K n/a
Investing Cash Flow -864.04K -225.97K -141.36K -62.35K -24.54K -329.99K -346.70K -72.25K -58.47K -29.57K 1.85M -2.10M 1.29M n/a -18.00K 1.14M 441.71K -1.45M -252.17K n/a
Debt Repayment n/a n/a n/a 184.00K -2.21K -3.04K -89.32K -246.08K -122.66K 4.00M -2.40K n/a -677.83K 2.98M n/a n/a n/a n/a 329.16K 216.17K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -40.00K n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a -2.24M -1.45M n/a n/a n/a n/a n/a n/a -5.11M -1.90M -740.28K -823.62K -261.12K n/a n/a
Other Financial Acitivies 22.94M -9.61M 1.21M 642.50K n/a 5.95M 6.56M 3.82M -470.73K -519.98K 70.54K 1.02M 28.36K 2.29M 11.10M 5.47M n/a n/a n/a n/a
Financial Cash Flow 22.94M 9.61M 1.25M 60.55M 9.02M 15.02M 9.93M 15.94M 2.71M 15.87M 5.04M 7.85M 9.52M 1.41M 18.14M 7.72M 12.83M 13.59M 6.91M 216.17K
Net Cash Flow -10.30M -15.84M -21.46M 46.55M -2.70M 3.25M -1.44M 7.59M -5.56M 7.00M -2.26M -828.41K 4.83M -6.40M 7.51M -8.48M -196.91K 5.67M 4.26M n/a
Free Cash Flow -33.24M -25.45M -22.71M -14.00M -11.72M -11.83M -11.37M -8.35M -8.27M -8.87M -9.30M -6.68M -6.09M -7.80M -10.64M -17.38M -13.49M -6.48M -2.42M -389.18K

Create Price Alert on CLRB

Your price alert will notify you when the stock price is above 0.25.

Add to Watchlist